Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Aclaris Therapts (ACRS)

Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Tue Dec 3, 3:30PM CST

ACRS : 2.72 (-1.81%)
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Tue Nov 26, 3:30PM CST

ACRS : 2.72 (-1.81%)
Aclaris Therapeutics Stock Surges On Licensing Deal, $80 Million Private Placement: Retail Sentiment Jumps Stocktwits - Tue Nov 19, 11:14AM CST

Leerink upgraded Aclaris to ‘Outperform’ from ‘Market Perform’ with its price target raised to $7 from $2; Piper Sandler upgraded the company to ‘Overweight’ from ‘Neutral.’

VHT : 253.89 (+1.23%)
VXF : 192.94 (+1.36%)
VTI : 293.28 (+1.14%)
ACRS : 2.72 (-1.81%)
Aclaris Therapeutics Secures $80 Million in Private Placement of Common Stock Quiver Quantitative, Inc. - Mon Nov 18, 5:36PM CST

Aclaris Therapeutics announced a private placement of 35.56 million shares, raising approximately $80 million for R&D and corporate purposes.Quiver AI SummaryAclaris Therapeutics, Inc. announced that it...

ACRS : 2.72 (-1.81%)
Aclaris Therapeutics Expands Pipeline with Exclusive Biosion License Agreement and Strengthens Leadership Team Quiver Quantitative, Inc. - Mon Nov 18, 5:36PM CST

Aclaris expands its pipeline with Biosion's innovative biologics, enhancing leadership and financial position for future growth.Quiver AI SummaryAclaris Therapeutics has announced a strategic advancement...

ACRS : 2.72 (-1.81%)
Aclaris Therapeutics Announces $80 Million Private Placement GlobeNewswire - Mon Nov 18, 7:10AM CST

ACRS : 2.72 (-1.81%)
Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline GlobeNewswire - Mon Nov 18, 7:10AM CST

ACRS : 2.72 (-1.81%)
Aclaris: Q3 Earnings Snapshot AP - Wed Nov 6, 6:07AM CST

Aclaris: Q3 Earnings Snapshot

ACRS : 2.72 (-1.81%)
Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update GlobeNewswire - Wed Nov 6, 6:00AM CST

ACRS : 2.72 (-1.81%)
Aclaris: Q2 Earnings Snapshot AP - Wed Aug 7, 6:20AM CDT

Aclaris: Q2 Earnings Snapshot

ACRS : 2.72 (-1.81%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot